MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer.
Petrelli A, Bellomo SE, Sarotto I, Kubatzki F, Sgandurra P, Maggiorotto F, Di Virgilio MR, Ponzone R, Geuna E, Galizia D, Nuzzo AM, Medico E, Miglio U, Berrino E, Venesio T, Ribisi S, Provero P, Sapino A, Giordano S, Montemurro F.
Petrelli A, et al. Among authors: montemurro f.
ESMO Open. 2020 Oct;5(5):e000937. doi: 10.1136/esmoopen-2020-000937.
ESMO Open. 2020.
PMID: 33122354
Free PMC article.